Global Meningococcal Conjugate Market Research Report 2023

Publisher Name :
Date: 11-Apr-2023
No. of pages: 93
Inquire Before Buying

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

Highlights

The global Meningococcal Conjugate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Meningococcal Conjugate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Meningococcal Conjugate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Meningococcal Conjugate in Children is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Meningococcal Conjugate include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meningococcal Conjugate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Conjugate.

The Meningococcal Conjugate market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Meningococcal Conjugate market comprehensively. Regional market sizes, concerning products by type, by end user, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Meningococcal Conjugate companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by end user, and by regions.

By Company

- Sanofi Pasteur

- Pfizer

- Glaxo Smith Kline

- Hualan Biological Engineering

- JN International Medical Corporation

- Baxter International

- Merck

- Serum Institute of India

- Biomed

- Novartis

Segment by Type

- Menactra

- Menveo

- NeisVac-C

- Nimenrix

- Others

Segment by End User

- Children

- Preteens or Teens

- Adults

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, end user, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meningococcal Conjugate companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Meningococcal Conjugate Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Menactra
1.2.3 Menveo
1.2.4 NeisVac-C
1.2.5 Nimenrix
1.2.6 Others
1.3 Market by End User
1.3.1 Global Meningococcal Conjugate Market Growth by End User: 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Preteens or Teens
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Conjugate Market Perspective (2018-2029)
2.2 Meningococcal Conjugate Growth Trends by Region
2.2.1 Global Meningococcal Conjugate Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Meningococcal Conjugate Historic Market Size by Region (2018-2023)
2.2.3 Meningococcal Conjugate Forecasted Market Size by Region (2024-2029)
2.3 Meningococcal Conjugate Market Dynamics
2.3.1 Meningococcal Conjugate Industry Trends
2.3.2 Meningococcal Conjugate Market Drivers
2.3.3 Meningococcal Conjugate Market Challenges
2.3.4 Meningococcal Conjugate Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Conjugate Players by Revenue
3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2018-2023)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2018-2023)
3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
3.4 Global Meningococcal Conjugate Market Concentration Ratio
3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2022
3.5 Meningococcal Conjugate Key Players Head office and Area Served
3.6 Key Players Meningococcal Conjugate Product Solution and Service
3.7 Date of Enter into Meningococcal Conjugate Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Conjugate Breakdown Data by Type
4.1 Global Meningococcal Conjugate Historic Market Size by Type (2018-2023)
4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2029)
5 Meningococcal Conjugate Breakdown Data by End User
5.1 Global Meningococcal Conjugate Historic Market Size by End User (2018-2023)
5.2 Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2029)
6 North America
6.1 North America Meningococcal Conjugate Market Size (2018-2029)
6.2 North America Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Meningococcal Conjugate Market Size by Country (2018-2023)
6.4 North America Meningococcal Conjugate Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Meningococcal Conjugate Market Size (2018-2029)
7.2 Europe Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Meningococcal Conjugate Market Size by Country (2018-2023)
7.4 Europe Meningococcal Conjugate Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Conjugate Market Size (2018-2029)
8.2 Asia-Pacific Meningococcal Conjugate Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Meningococcal Conjugate Market Size by Region (2018-2023)
8.4 Asia-Pacific Meningococcal Conjugate Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Meningococcal Conjugate Market Size (2018-2029)
9.2 Latin America Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Meningococcal Conjugate Market Size by Country (2018-2023)
9.4 Latin America Meningococcal Conjugate Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Conjugate Market Size (2018-2029)
10.2 Middle East & Africa Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Meningococcal Conjugate Market Size by Country (2018-2023)
10.4 Middle East & Africa Meningococcal Conjugate Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Detail
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
11.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2018-2023)
11.1.5 Sanofi Pasteur Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Meningococcal Conjugate Introduction
11.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Detail
11.3.2 Glaxo Smith Kline Business Overview
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
11.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2018-2023)
11.3.5 Glaxo Smith Kline Recent Development
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Detail
11.4.2 Hualan Biological Engineering Business Overview
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
11.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2018-2023)
11.4.5 Hualan Biological Engineering Recent Development
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Detail
11.5.2 JN International Medical Corporation Business Overview
11.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
11.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2018-2023)
11.5.5 JN International Medical Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Detail
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Meningococcal Conjugate Introduction
11.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2018-2023)
11.6.5 Baxter International Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Meningococcal Conjugate Introduction
11.7.4 Merck Revenue in Meningococcal Conjugate Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Detail
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Meningococcal Conjugate Introduction
11.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2018-2023)
11.8.5 Serum Institute of India Recent Development
11.9 Biomed
11.9.1 Biomed Company Detail
11.9.2 Biomed Business Overview
11.9.3 Biomed Meningococcal Conjugate Introduction
11.9.4 Biomed Revenue in Meningococcal Conjugate Business (2018-2023)
11.9.5 Biomed Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Meningococcal Conjugate Introduction
11.10.4 Novartis Revenue in Meningococcal Conjugate Business (2018-2023)
11.10.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Menactra
Table 3. Key Players of Menveo
Table 4. Key Players of NeisVac-C
Table 5. Key Players of Nimenrix
Table 6. Key Players of Others
Table 7. Global Meningococcal Conjugate Market Size Growth by End User (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Meningococcal Conjugate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Meningococcal Conjugate Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Meningococcal Conjugate Market Share by Region (2018-2023)
Table 11. Global Meningococcal Conjugate Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Meningococcal Conjugate Market Share by Region (2024-2029)
Table 13. Meningococcal Conjugate Market Trends
Table 14. Meningococcal Conjugate Market Drivers
Table 15. Meningococcal Conjugate Market Challenges
Table 16. Meningococcal Conjugate Market Restraints
Table 17. Global Meningococcal Conjugate Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Meningococcal Conjugate Market Share by Players (2018-2023)
Table 19. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)
Table 20. Ranking of Global Top Meningococcal Conjugate Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Conjugate Product Solution and Service
Table 24. Date of Enter into Meningococcal Conjugate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2018-2023)
Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2024-2029)
Table 30. Global Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)
Table 31. Global Meningococcal Conjugate Revenue Market Share by End User (2018-2023)
Table 32. Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2029) & (US$ Million)
Table 33. Global Meningococcal Conjugate Revenue Market Share by End User (2024-2029)
Table 34. North America Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Meningococcal Conjugate Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Meningococcal Conjugate Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Meningococcal Conjugate Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)
Table 49. Sanofi Pasteur Company Detail
Table 50. Sanofi Pasteur Business Overview
Table 51. Sanofi Pasteur Meningococcal Conjugate Product
Table 52. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 53. Sanofi Pasteur Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Meningococcal Conjugate Product
Table 57. Pfizer Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Glaxo Smith Kline Company Detail
Table 60. Glaxo Smith Kline Business Overview
Table 61. Glaxo Smith Kline Meningococcal Conjugate Product
Table 62. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 63. Glaxo Smith Kline Recent Development
Table 64. Hualan Biological Engineering Company Detail
Table 65. Hualan Biological Engineering Business Overview
Table 66. Hualan Biological Engineering Meningococcal Conjugate Product
Table 67. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 68. Hualan Biological Engineering Recent Development
Table 69. JN International Medical Corporation Company Detail
Table 70. JN International Medical Corporation Business Overview
Table 71. JN International Medical Corporation Meningococcal Conjugate Product
Table 72. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 73. JN International Medical Corporation Recent Development
Table 74. Baxter International Company Detail
Table 75. Baxter International Business Overview
Table 76. Baxter International Meningococcal Conjugate Product
Table 77. Baxter International Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 78. Baxter International Recent Development
Table 79. Merck Company Detail
Table 80. Merck Business Overview
Table 81. Merck Meningococcal Conjugate Product
Table 82. Merck Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Serum Institute of India Company Detail
Table 85. Serum Institute of India Business Overview
Table 86. Serum Institute of India Meningococcal Conjugate Product
Table 87. Serum Institute of India Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 88. Serum Institute of India Recent Development
Table 89. Biomed Company Detail
Table 90. Biomed Business Overview
Table 91. Biomed Meningococcal Conjugate Product
Table 92. Biomed Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 93. Biomed Recent Development
Table 94. Novartis Company Detail
Table 95. Novartis Business Overview
Table 96. Novartis Meningococcal Conjugate Product
Table 97. Novartis Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 98. Novartis Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Meningococcal Conjugate Market Share by Type: 2022 VS 2029
Figure 3. Menactra Features
Figure 4. Menveo Features
Figure 5. NeisVac-C Features
Figure 6. Nimenrix Features
Figure 7. Others Features
Figure 8. Global Meningococcal Conjugate Market Size Comparison by End User (2023-2029) & (US$ Million)
Figure 9. Global Meningococcal Conjugate Market Share by End User: 2022 VS 2029
Figure 10. Children Case Studies
Figure 11. Preteens or Teens Case Studies
Figure 12. Adults Case Studies
Figure 13. Meningococcal Conjugate Report Years Considered
Figure 14. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Meningococcal Conjugate Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Meningococcal Conjugate Market Share by Region: 2022 VS 2029
Figure 17. Global Meningococcal Conjugate Market Share by Players in 2022
Figure 18. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2022
Figure 20. North America Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Meningococcal Conjugate Market Share by Country (2018-2029)
Figure 22. United States Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Meningococcal Conjugate Market Share by Country (2018-2029)
Figure 26. Germany Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Meningococcal Conjugate Market Share by Region (2018-2029)
Figure 34. China Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Meningococcal Conjugate Market Share by Country (2018-2029)
Figure 42. Mexico Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Meningococcal Conjugate Market Share by Country (2018-2029)
Figure 46. Turkey Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 50. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 51. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 52. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 53. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 55. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 56. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs